Concepedia

Élodie Montaudon

ÉM

20

Publications

1.1K

Citations

16

H-Index

2014

Active since

Affiliations

Institut Curie(Current)

Inserm

Université Paris Sciences et Lettres

École Nationale Vétérinaire d'Alfort

Oniris

Élodie Montaudon is an author at Institut Curie specializing in medicine, vascular biology, and molecular pharmacology.

ORCID

Top concepts

Publications per year

2014–2023

20

Publications

20

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers

Florence Coussy, Rania El Botty, Sophie Château‐Joubert et al. · Science Translational Medicine · 2020 · 132 citations · Full text

Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance

Mingjun Bi, Zhao Zhang, Yi‐Zhou Jiang et al. · Nature Cell Biology · 2020 · 131 citations · Full text

, , +10

PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance

Élodie Montaudon, Joanna Nikitorowicz-Buniak, Laura Sourd et al. · Nature Communications · 2020 · 122 citations · Full text

Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities

Sunil Pancholi, Ricardo Ribas, Nikiana Simigdala et al. · Oncogene · 2020 · 88 citations · Full text

Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers

Rania El Botty, Ludivine Morriset, Élodie Montaudon et al. · Nature Communications · 2023 · 84 citations · Full text

Rows per page

1–5 of 20